Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BluHaven Management is the private family office and investment vehicle for Robert Nelsen, a co-founder and Managing Director of ARCH Venture Partners. The firm specializes in strategic investments across the life sciences, biotechnology, and healthcare sectors, focusing on disruptive technologies and breakthrough therapies. BluHaven often participates in early-stage financing rounds for companies developing advanced modalities such as cell and gene therapies, oncology treatments, and genomic medicines. By utilizing the deep industry insights of its leadership, the firm provides critical capital and strategic support to innovative startups aiming to address significant unmet medical needs. The entity operates as a key player in the biotech venture ecosystem, maintaining a portfolio of high-growth companies at the forefront of medical science.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BluHaven Management.